000			01564 a2200457 4500
005			20250512053943.0
264		0	_c19870226
008			198702s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/1097-0142(19870115)59:2<301::aid-cncr2820590222>3.0.co;2-w _2doi
040			_aNLM _beng _cNLM
100	1		_ade Gramont, A
245	0	0	_aErythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease. _h[electronic resource]
260			_bCancer _cJan 1987
300			_a301-4 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aErythrocyte Indices
650	0	4	_aHodgkin Disease _xblood
650	0	4	_aHumans
650	0	4	_aLeukemia, Lymphoid _xetiology
650	0	4	_aMathematics
650	0	4	_aMechlorethamine _xtherapeutic use
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aProcarbazine _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aRisk
650	0	4	_aTime Factors
650	0	4	_aVincristine _xtherapeutic use
700	1		_aLouvet, C
700	1		_aKrulik, M
700	1		_aSmadja, N
700	1		_aDonadio, D
700	1		_aLaporte, J P
700	1		_aBrissaud, P
700	1		_aDelâge, J M
700	1		_aDrolet, Y
700	1		_aRioux, E
773	0		_tCancer _gvol. 59 _gno. 2 _gp. 301-4
856	4	0	_uhttps://doi.org/10.1002/1097-0142(19870115)59:2<301::aid-cncr2820590222>3.0.co;2-w _zAvailable from publisher's website
999			_c3473550 _d3473550